These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10487469)
21. Drugs and acute porphyrias: reasons for a hazardous relationship. Roveri G; Nascimbeni F; Rocchi E; Ventura P Postgrad Med; 2014 Nov; 126(7):108-20. PubMed ID: 25387219 [TBL] [Abstract][Full Text] [Related]
22. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria. Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903 [TBL] [Abstract][Full Text] [Related]
23. Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria. Szlendak U; Bykowska K; Lipniacka A Adv Clin Exp Med; 2016; 25(2):361-8. PubMed ID: 27627571 [TBL] [Abstract][Full Text] [Related]
24. Acute porphyrias: diagnosis and management. Tefferi A; Colgan JP; Solberg LA Mayo Clin Proc; 1994 Oct; 69(10):991-5. PubMed ID: 7934198 [TBL] [Abstract][Full Text] [Related]
25. Systemic lupus erythematosus and acute intermittent porphyria. Allard SA; Scott JT Br J Rheumatol; 1989 Jun; 28(3):254-6. PubMed ID: 2730987 [TBL] [Abstract][Full Text] [Related]
26. Best practice guidelines on first-line laboratory testing for porphyria. Woolf J; Marsden JT; Degg T; Whatley S; Reed P; Brazil N; Stewart MF; Badminton M Ann Clin Biochem; 2017 Mar; 54(2):188-198. PubMed ID: 27555665 [TBL] [Abstract][Full Text] [Related]